229 related articles for article (PubMed ID: 24176545)
1. Presence of osteoclast precursor cells during ex vivo expansion of bone marrow-derived mesenchymal stem cells for autologous use in cell therapy.
Allers C; Lasala GP; Minguell JJ
Cytotherapy; 2014 Apr; 16(4):454-9. PubMed ID: 24176545
[TBL] [Abstract][Full Text] [Related]
2. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
3. Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device.
Otsuru S; Hofmann TJ; Olson TS; Dominici M; Horwitz EM
Cytotherapy; 2013 Feb; 15(2):146-53. PubMed ID: 23321326
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H
Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679
[TBL] [Abstract][Full Text] [Related]
5. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human.
Liu L; Sun Z; Chen B; Han Q; Liao L; Jia M; Cao Y; Ma J; Sun Q; Guo M; Liu Z; Ai H; Zhao RC
Stem Cells Dev; 2006 Jun; 15(3):349-57. PubMed ID: 16846373
[TBL] [Abstract][Full Text] [Related]
8. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
[TBL] [Abstract][Full Text] [Related]
9. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow mesenchymal stem cell aspirates from alternative sources: is the knee as good as the iliac crest?
Narbona-Carceles J; Vaquero J; Suárez-Sancho S; Forriol F; Fernández-Santos ME
Injury; 2014 Oct; 45 Suppl 4():S42-7. PubMed ID: 25384474
[TBL] [Abstract][Full Text] [Related]
12. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
[TBL] [Abstract][Full Text] [Related]
13. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
[TBL] [Abstract][Full Text] [Related]
14. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
Mareschi K; Ferrero I; Rustichelli D; Aschero S; Gammaitoni L; Aglietta M; Madon E; Fagioli F
J Cell Biochem; 2006 Mar; 97(4):744-54. PubMed ID: 16229018
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of mesenchymal stromal cells.
Bernardo ME; Cometa AM; Pagliara D; Vinti L; Rossi F; Cristantielli R; Palumbo G; Locatelli F
Best Pract Res Clin Haematol; 2011 Mar; 24(1):73-81. PubMed ID: 21396595
[TBL] [Abstract][Full Text] [Related]
16. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
17. Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells.
Bernardi M; Albiero E; Alghisi A; Chieregato K; Lievore C; Madeo D; Rodeghiero F; Astori G
Cytotherapy; 2013 Aug; 15(8):920-9. PubMed ID: 23623274
[TBL] [Abstract][Full Text] [Related]
18. GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system.
Rojewski MT; Fekete N; Baila S; Nguyen K; Fürst D; Antwiler D; Dausend J; Kreja L; Ignatius A; Sensebé L; Schrezenmeier H
Cell Transplant; 2013; 22(11):1981-2000. PubMed ID: 23107560
[TBL] [Abstract][Full Text] [Related]
19. Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation.
Sohn HS; Heo JS; Kim HS; Choi Y; Kim HO
Cytotherapy; 2013 Apr; 15(4):460-6. PubMed ID: 23318345
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
